Reaction
Injection Site Macule reporting signals
As of the last recalculation, Injection Site Macule appears in 683 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is ETANERCEPT (PRR 74.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Etanercept | 470 | 74.5 | 74.6 |
| Galcanezumab-Gnlm | 8 | 7.8 | 7.8 |
| Evolocumab | 21 | 4.0 | 4.0 |